Patientis Undergoing Laparatomy.
Conditions
Interventions
Intervention 1: Intervention Group: ultrasound-guided paravertebral block with ropivacaine hydrochloride 0.2% ( Naropin 10mg/ml, 10ml polyamp, ASTRAZENECA ) 20 cc for each side in T7-T8 level plus con
Treatment - Drugs
Intervention Group: ultrasound-guided paravertebral block with ropivacaine hydrochloride 0.2% ( Naropin 10mg/ml, 10ml polyamp, ASTRAZENECA ) 20 cc for each side in T7-T8 level plus continuous intraven
Control Group: continuous intravenous analgesia (CIA) filled with fentanyl (Fentanyl, Abureyhan, Iran) 20cc with 80cc normal saline with infusion rate of 4ml/hour.
Sponsors
Vice Chancellor for Research of Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: American Society of Anesthesiologists (ASA) I–III patients scheduled for upper abdominal laparotomy who ranged in age from 18–80 years. Patients were excluded if they exhibited a contraindication to regional anesthesia (preoperative homeostasis disorder or a local or general infection), history of allergic reaction to local anesthetic , a past medical history of asthma, chronic renal failure or hepatic dysfunction, history of opium abuse; history of neurological, neuromuscular or psychological disorders and pregnancy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post Operative Pain. Timepoint: 2,6,12,24,48 Hour After Operation. Method of measurement: Visual Analog Scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Total Dosage of Opioid. Timepoint: During 48 Hours after Surgery. Method of measurement: mg/ Nursing Report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarnad Imani
Tehran University of Medical ciences
Outcome results
None listed